Abstract
Of the 10,730 neonates born in the period 1978–1997 and examined for cryptorchidism (C) at birth, 1387 were pre-term (gestational age <37 wk), and 9343 were full-term. At birth, a total of 737 neonates (6.9%) were cryptorchid, 487 had bilateral C and 250 unilateral C. The C rate of pre-terms was 10 times higher than that of the full-terms (30.1 and 3.4%, respectively). Comparing the two studied decades, a significant decrease of C rate was found in the second decade in full-term neonates. The rates of C at birth were significantly elevated for low birth weight, babies born from mothers with an age <20 or >35 yr, newborns from mothers with A Rh positive and B Rh positive blood group. Of the 737 cryptorchid newborns at birth, 613 (83%) were re-examined after 12 months from the expected date of delivery, and those born in the period 1988–1997 were also re-evaluated at 6 months of life. Late spontaneous descent occurred in 464 cases (75.7%), while 149 (24.3%) were still cryptorchid. The incidence of C at 12 months from the expected date of delivery, after survival curve calculation, in term and pre-term infants, was 1.53 and 7.31%, respectively, in the period 1978–1987, and 1.22 and 3.13% respectively, in the 2nd decade (1988–1997). In the groups also examined at 6 months of life, spontaneous descent occurred almost completely within the first 6 months of life in term infants, but not in pre-terms. No evidence of seasonal cyclicity was found. Medical and/or surgical treatment was generally started within 2–4 yr of age earlier in the second decade of the study. In conclusion, the main risk factor for C at birth and at 12 months of life seems to be preterm birth and low birth weight. If this is associated itself to a higher risk of infertility too, it remains to be defined.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Chilvers C., Dudley N.E., Gough M.H., Jackson M.B., Pike M.C.. Undescended testis: the effect of treatment on subsequent risk of subfertility and malignancy. J. Pediatr. Surg. 1986, 21: 691–696.
Lee P.A., O’Leary L.A., Songer N.J., Bellinger M.F., LaPorte R.E.. Paternity after cryptorchidism: lack of correlation with age at orchidopexy. Br. J. Urol. 1995, 75: 704–706.
Miller H., Prener A., Skakkebaek N.E. Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark. Cancer Causes Control 1996, 7: 264–274.
Moss A.R., Osmond D., Bacchetti P., Torti F.M., Gurgin V. Hormonal risk factors in testicular cancer. A case-control study. Am. J. Epidemiol. 1986, 124: 39–52.
Schottenfeld D., Warshauer M.E., Sherlock S., Zauber A.G., Leder M., Payne R. The epidemiology of testicular cancer in young adults. Am. J. Epidemiol. 1980, 112: 232–246.
Swerdlow A.J., Higgins C.D., Pike M.C. Risk of testicular cancer in cohort of boys with cryptorchidism. B.M.J. 1997, 314: 1507–1511.
Scorer C.G. The descent of the testis. Arch. Dis. Child. 1964, 39: 605–609.
John Radcliffe Hospital Cryptorchidism Study Group. Cryptorchidism: a prospective study of 7,500 consecutive male births, 1984-8. Arch. Dis. Child. 1992, 67: 892–899.
Berkowitz G.S., Lapinski R.H. Risk factors for cryptorchidism: a nested case-control study. Paediatr. Perinat. Epidemiol. 1996, 10: 39–51.
Thong M.K., Lim C.T., Fatimah H. Undescended testes: incidence in 1002 consecutive male infants and outcome at 1 year of age. Pediatr. Surg. Int. 1998, 13: 37–41.
Scorer C.G. The incidence of incomplete descent of the testicle at birth. Arch. Dis. Child. 1956, 31: 198–202.
Elder J.S. The undescended testis. Hormonal and surgical management. Surg. Clin. North Am. 1988, 68: 983–1005.
Huff D.S., Hadziselimovic F., Snyder H.M. 3rd, Duckett J.W., Keating M.A. Postnatal testicular maldevelopment in unilateral cryptorchidism. J. Urol. 1989, 142: 546–548.
Huff D.S., Hadziselimovic F., Snyder H.M. 3rd, Blyth B., Duckett J.W. Early postnatal testicular maldevelopment in cryptorchidism. J. Urol. 1991, 146: 624–626.
Nagar H., Haddad R. Impact of early orchidopexy on testicular growth. Br. J. Urol. 1997, 80: 334–335.
Chilvers C., Dudley N.E., Gough M.H., et al. Epidemiology of undescended testis. In: Oliver R.T.D., Blandy J.P., Hope-Stone F. (Eds.), Urological and genital cancer. Blackwell Scientific Publications, Oxford, 1989, p. 306.
Pike M.C., Chilvers C., Peckham M.J. Effect of age at orchidopexy on risk of testicular cancer. Lancet 1986, 1: 1246–1248.
Pedrotti D., Macagno F., Gagliardi L., et al. Standard neonatali di crescita intrauterina elaborati dalla “Task force” della SIN. Sininforma 1997, III 1: 1–4.
Altman D.G. Practical statistics for medical research. Chapman & Hall, London, 1991.
Walter S.D., Elwood J.M. A test for seasonality of events with a variable population at risk. Br. J. Prev. Soc. Med. 1975, 29: 1–21.
Gill B., Kogan S. Cryptorchidism: current concepts. Pediatr. Clin. North Am. 1997, 44: 1211–1227.
Hutson J.M., Hasthorpe S., Heyns C.F. Anatomical and functional aspects of testicular descent and cryptorchidism. Endocr. Rev. 1997, 18: 259–280.
Heyns C.F., Hutson J.M. Historical review of theories on testicular descent. J. Urol. 1995, 153: 754–767.
Husmann D.S., Levy J.B. Current concepts in the pathophysiology of testicular undescent. Urology 1995, 46: 267–276.
Swerdlow A.J., Wood K.H., Smith P.G. A case-control study of the aetiology of cryptorchidism. J. Epidemiol. Community Health 1983, 37: 238–244.
John Radcliffe Hospital Cryptorchidism Study Group. Cryptorchidism: an apparent substantial increase since 1960. B.M.J. 1986, 293: 1401–1404.
Davey RB. Undescended testes: early versus late maldescent. Pediatr. Surg. Int. 1997, 12: 165–167.
Donnel S.C., Rickwood A.M., Jee L.D., Jackson M. Congenital testicular maldescent: significance of the complete hernial sac. Br. J. Urol. 1995, 75: 702–703.
Geffner M.E., Lippe B.M. Genetic and endocrinologic syndromes associated with cryptorchidism. In: Fonkalsrud E.W., Mengel W. (Eds.), The undescended testis. Year Book Medical Publishers, Chicago, 1981, p. 135.
Job J.C., Toublanc J.E., Chaussain J.L., et al. The pituitarygonadal axis in cryptorchid infants and children. Eur. J. Pediatr. 1987, 146 (Suppl. 2): p. S2–S5.
Baker B.A., Morley R., Lucas A. Plasma testosterone in preterm infants with cryptorchidism. Arch. Dis. Child. 1988, 63: 1198–1200.
Berkowitz G.S., Lapinski R.H., Dolgin S.E., Gazella J.G., Bodian C.A., Holzman I.R. Prevalence and natural history of cryptorchidism. Pediatrics 1993, 92: 44–49.
Hjertkvist M., Damber J.E., Bergh A. Cryptorchidism: a registry based study in Sweden on some factors of possible aetiological importance. J. Epidemiol. Community Health 1989, 43: 324–329.
Boldrini A., Ghirri P., Cuttano A., et al. Epidemiologia del criptorchidismo in età neonatale. Giornale Italiano di Andrologia 1997, 3: 145–148.
Berkowitz G.S., Lapinski R.H., Godbold J.H., Dolgin S.E., Holzman I.R. Maternal and neonatal risk factors for cryptorchidism. Epidemiology 1995, 6: 127–131.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ghirri, P., Ciulli, C., Vuerich, M. et al. Incidence at birth and natural history of cryptorchidism: A study of 10,730 consecutive male infants. J Endocrinol Invest 25, 709–715 (2002). https://doi.org/10.1007/BF03345105
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345105